| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,250 | $30 | $280.5K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 35,200 | $1 | $140.8K |
| J3262 | Injection, tocilizumab, 1 mg | 25,720 | $10 | $128.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 710 | $70 | $49.1K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 3,150 | $10 | $34.6K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 3,990 | $10 | $31.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,130 | $20 | $25.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 90 | $80 | $7.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 130 | $40 | $5.1K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 280 | $20 | $5K |